Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,15500Cr 1.23TCr 1.12TCr 1.03TCr 933.04Cr 1.76TCr 1.82TCr 12TCr 4.92TCr 62TCr 4.62TCr 4.52TCr 1,96400Cr P/E 2027 *
31.5x
P/E 2028 * 23.7x
Enterprise Value 1,12500Cr 1.2TCr 1.09TCr 1.01TCr 908.61Cr 1.71TCr 1.78TCr 12TCr 4.79TCr 60TCr 4.5TCr 4.4TCr 1,91300Cr EV / Sales 2027 *
3.2x
EV / Sales 2028 * 2.81x
Free-Float
68.54%
Yield 2027 *
0.54%
Yield 2028 * 0.6%
1 day+1.26%
1 week-0.07%
Current month+4.80%
1 month+13.53%
3 months+22.63%
6 months+9.19%
Current year+5.77%
1 week 14.6
Extreme 14.605
14.94
1 month 13.02
Extreme 13.015
15.08
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-0.07% - - 1.22TCr
-1.01%-1.47%+38.12%+138.50% 1,27500Cr
-0.63%-0.21%+40.38%+87.05% 68TCr
-0.38%-0.40%+25.09%+111.66% 52TCr
-0.76%+1.10%+41.43%+70.96% 39TCr
-0.25%-3.04%+54.59%+41.08% 36TCr
-1.83%-0.89%+26.00%+58.48% 31TCr
-1.65%-0.59%+1.55%+34.52% 29TCr
-0.61%-1.55%+34.04%+72.59% 25TCr
+1.55%-0.69%+36.75%+124.91% 21TCr
Average -0.59%+0.51%+33.11%+82.19% 47TCr
Weighted average by Cap. -0.89%+0.76%+34.94%+95.53%

Financials

2027 *2028 *
Net sales 35TCr 374.16Cr 339.92Cr 314.07Cr 283.69Cr 535.38Cr 554.21Cr 3.78TCr 1.5TCr 19TCr 1.4TCr 1.37TCr 60TCr 39TCr 418.89Cr 380.56Cr 351.62Cr 317.61Cr 599.38Cr 620.46Cr 4.23TCr 1.68TCr 21TCr 1.57TCr 1.54TCr 67TCr
Net income 3.65TCr 39Cr 35Cr 33Cr 29Cr 56Cr 58Cr 392.62Cr 155.57Cr 1.96TCr 145.95Cr 142.86Cr 6.21TCr 4.93TCr 53Cr 48Cr 44Cr 40Cr 75Cr 78Cr 530.21Cr 210.08Cr 2.65TCr 197.09Cr 192.92Cr 8.38TCr
Net Debt -3.03TCr -32Cr -29Cr -27Cr -24Cr -46Cr -48Cr -325.24Cr -128.87Cr -1.62TCr -120.9Cr -118.34Cr -5.14TCr -4.95TCr -53Cr -48Cr -44Cr -40Cr -75Cr -78Cr -531.66Cr -210.65Cr -2.65TCr -197.63Cr -193.45Cr -8.41TCr
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
17/26/17 $14.86 +1.11% 5,68,640
16/26/16 $14.70 -0.27% 12,32,011
13/26/13 $14.74 +0.07% 37,13,807
12/26/12 $14.73 -0.74% 16,54,035
11/26/11 $14.84 -0.13% 21,76,818
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,387.00INR
Average target price
1,364.41INR
Spread / Average Target
-1.63%